XML 67 R52.htm IDEA: XBRL DOCUMENT
v3.25.4

Revenues - Schedule of Revenue by Payor Type (Details) - USD ($) $ in Thousands | 12 Months Ended
--- | ---
Dec. 31, 2025 | Dec. 31, 2024 | Dec. 31, 2023
Disaggregation of Revenue [Line Items] |  |  |
Revenues | $ 12,910,564 | $ 10,072,214 | $ 7,691,016
Commercial Insurance |  |  |
Disaggregation of Revenue [Line Items] |  |  |
Revenues | 3,303,300 | 2,528,100 | 1,810,200
Medicaid |  |  |
Disaggregation of Revenue [Line Items] |  |  |
Revenues | 1,495,200 | 1,166,500 | 979,100
Medicare Part A |  |  |
Disaggregation of Revenue [Line Items] |  |  |
Revenues | 1,094,300 | 999,600 | 958,600
Medicare Part B |  |  |
Disaggregation of Revenue [Line Items] |  |  |
Revenues | 82,800 | 95,900 | 82,800
Medicare Part C |  |  |
Disaggregation of Revenue [Line Items] |  |  |
Revenues | 2,413,100 | 1,665,000 | 1,450,400
Medicare Part D |  |  |
Disaggregation of Revenue [Line Items] |  |  |
Revenues | 4,097,800 | 3,202,000 | 2,031,900
Private and Other |  |  |
Disaggregation of Revenue [Line Items] |  |  |
Revenues | 424,100 | 415,100 | 378,000
Pharmacy Solutions |  |  |
Disaggregation of Revenue [Line Items] |  |  |
Revenues | 11,445,800 | 8,754,300 | 6,522,500
Pharmacy Solutions | Commercial Insurance |  |  |
Disaggregation of Revenue [Line Items] |  |  |
Revenues | 3,114,600 | 2,360,000 | 1,657,700
Pharmacy Solutions | Medicaid |  |  |
Disaggregation of Revenue [Line Items] |  |  |
Revenues | 1,093,200 | 829,100 | 656,100
Pharmacy Solutions | Medicare Part A |  |  |
Disaggregation of Revenue [Line Items] |  |  |
Revenues | 572,800 | 546,400 | 549,300
Pharmacy Solutions | Medicare Part B |  |  |
Disaggregation of Revenue [Line Items] |  |  |
Revenues | 76,400 | 70,300 | 61,200
Pharmacy Solutions | Medicare Part C |  |  |
Disaggregation of Revenue [Line Items] |  |  |
Revenues | 2,277,500 | 1,547,100 | 1,384,300
Pharmacy Solutions | Medicare Part D |  |  |
Disaggregation of Revenue [Line Items] |  |  |
Revenues | 4,097,800 | 3,202,000 | 2,031,900
Pharmacy Solutions | Private and Other |  |  |
Disaggregation of Revenue [Line Items] |  |  |
Revenues | 213,500 | 199,400 | 182,000
Provider Services |  |  |
Disaggregation of Revenue [Line Items] |  |  |
Revenues | 1,464,800 | 1,317,900 | 1,168,500
Provider Services | Commercial Insurance |  |  |
Disaggregation of Revenue [Line Items] |  |  |
Revenues | 188,700 | 168,100 | 152,500
Provider Services | Medicaid |  |  |
Disaggregation of Revenue [Line Items] |  |  |
Revenues | 402,000 | 337,400 | 323,000
Provider Services | Medicare Part A |  |  |
Disaggregation of Revenue [Line Items] |  |  |
Revenues | 521,500 | 453,200 | 409,300
Provider Services | Medicare Part B |  |  |
Disaggregation of Revenue [Line Items] |  |  |
Revenues | 6,400 | 25,600 | 21,600
Provider Services | Medicare Part C |  |  |
Disaggregation of Revenue [Line Items] |  |  |
Revenues | 135,600 | 117,900 | 66,100
Provider Services | Private and Other |  |  |
Disaggregation of Revenue [Line Items] |  |  |
Revenues | $ 210,600 | $ 215,700 | $ 196,000
Product Concentration Risk | Revenue |  |  |
Disaggregation of Revenue [Line Items] |  |  |
% of Revenue | 100.00% | 100.00% | 100.00%
Product Concentration Risk | Revenue | Commercial Insurance |  |  |
Disaggregation of Revenue [Line Items] |  |  |
% of Revenue | 25.60% | 25.10% | 23.60%
Product Concentration Risk | Revenue | Medicaid |  |  |
Disaggregation of Revenue [Line Items] |  |  |
% of Revenue | 11.60% | 11.50% | 12.70%
Product Concentration Risk | Revenue | Medicare Part A |  |  |
Disaggregation of Revenue [Line Items] |  |  |
% of Revenue | 8.40% | 9.90% | 12.40%
Product Concentration Risk | Revenue | Medicare Part B |  |  |
Disaggregation of Revenue [Line Items] |  |  |
% of Revenue | 0.60% | 1.00% | 1.10%
Product Concentration Risk | Revenue | Medicare Part C |  |  |
Disaggregation of Revenue [Line Items] |  |  |
% of Revenue | 18.70% | 16.60% | 18.90%
Product Concentration Risk | Revenue | Medicare Part D |  |  |
Disaggregation of Revenue [Line Items] |  |  |
% of Revenue | 31.70% | 31.80% | 26.40%
Product Concentration Risk | Revenue | Private and Other |  |  |
Disaggregation of Revenue [Line Items] |  |  |
% of Revenue | 3.40% | 4.10% | 4.90%
Product Concentration Risk | Revenue | Pharmacy Solutions |  |  |
Disaggregation of Revenue [Line Items] |  |  |
% of Revenue | 88.70% | 86.90% | 84.80%
Product Concentration Risk | Revenue | Pharmacy Solutions | Commercial Insurance |  |  |
Disaggregation of Revenue [Line Items] |  |  |
% of Revenue | 24.10% | 23.40% | 21.60%
Product Concentration Risk | Revenue | Pharmacy Solutions | Medicaid |  |  |
Disaggregation of Revenue [Line Items] |  |  |
% of Revenue | 8.50% | 8.20% | 8.50%
Product Concentration Risk | Revenue | Pharmacy Solutions | Medicare Part A |  |  |
Disaggregation of Revenue [Line Items] |  |  |
% of Revenue | 4.40% | 5.40% | 7.10%
Product Concentration Risk | Revenue | Pharmacy Solutions | Medicare Part B |  |  |
Disaggregation of Revenue [Line Items] |  |  |
% of Revenue | 0.60% | 0.70% | 0.80%
Product Concentration Risk | Revenue | Pharmacy Solutions | Medicare Part C |  |  |
Disaggregation of Revenue [Line Items] |  |  |
% of Revenue | 17.60% | 15.40% | 18.00%
Product Concentration Risk | Revenue | Pharmacy Solutions | Medicare Part D |  |  |
Disaggregation of Revenue [Line Items] |  |  |
% of Revenue | 31.70% | 31.80% | 26.40%
Product Concentration Risk | Revenue | Pharmacy Solutions | Private and Other |  |  |
Disaggregation of Revenue [Line Items] |  |  |
% of Revenue | 1.80% | 2.00% | 2.40%
Product Concentration Risk | Revenue | Provider Services |  |  |
Disaggregation of Revenue [Line Items] |  |  |
% of Revenue | 11.30% | 13.10% | 15.20%
Product Concentration Risk | Revenue | Provider Services | Commercial Insurance |  |  |
Disaggregation of Revenue [Line Items] |  |  |
% of Revenue | 1.50% | 1.70% | 2.00%
Product Concentration Risk | Revenue | Provider Services | Medicaid |  |  |
Disaggregation of Revenue [Line Items] |  |  |
% of Revenue | 3.10% | 3.30% | 4.20%
Product Concentration Risk | Revenue | Provider Services | Medicare Part A |  |  |
Disaggregation of Revenue [Line Items] |  |  |
% of Revenue | 4.00% | 4.50% | 5.30%
Product Concentration Risk | Revenue | Provider Services | Medicare Part B |  |  |
Disaggregation of Revenue [Line Items] |  |  |
% of Revenue | 0.00% | 0.30% | 0.30%
Product Concentration Risk | Revenue | Provider Services | Medicare Part C |  |  |
Disaggregation of Revenue [Line Items] |  |  |
% of Revenue | 1.10% | 1.20% | 0.90%
Product Concentration Risk | Revenue | Provider Services | Private and Other |  |  |
Disaggregation of Revenue [Line Items] |  |  |
% of Revenue | 1.60% | 2.10% | 2.50%

X
- Definition For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 42 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-42 Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 275 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 18 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482861/275-10-50-18 Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 275 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 18 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482861/275-10-50-18 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 275 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 20 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482861/275-10-50-20 Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 275 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 18 -Subparagraph (d) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482861/275-10-50-18 Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 275 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 18 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482861/275-10-50-18 Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 275 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 18 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482861/275-10-50-18 + Details
Name: | us-gaap_ConcentrationRiskPercentage1
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 7 -Publisher FASB -URI https://asc.fasb.org/1943274/2147479806/606-10-50-7 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 5 -Publisher FASB -URI https://asc.fasb.org/1943274/2147479806/606-10-50-5 Reference 3: http://www.xbrl.org/2003/role/exampleRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 91 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479777/606-10-55-91 Reference 4: http://www.xbrl.org/2003/role/exampleRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 91 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479777/606-10-55-91 Reference 5: http://www.xbrl.org/2003/role/exampleRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 91 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479777/606-10-55-91 Reference 6: http://www.xbrl.org/2003/role/exampleRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 91 -Subparagraph (d) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479777/606-10-55-91 Reference 7: http://www.xbrl.org/2003/role/exampleRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 91 -Subparagraph (e) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479777/606-10-55-91 Reference 8: http://www.xbrl.org/2003/role/exampleRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 91 -Subparagraph (f) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479777/606-10-55-91 Reference 9: http://www.xbrl.org/2003/role/exampleRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 91 -Subparagraph (g) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479777/606-10-55-91 + Details
Name: | us-gaap_DisaggregationOfRevenueLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise. + References Reference 1: http://www.xbrl.org/2003/role/exampleRef -Topic 220 -SubTopic 40 -Name Accounting Standards Codification -Section 55 -Paragraph 4 -Publisher FASB -URI https://asc.fasb.org/1943274/2147476153/220-40-55-4 Reference 2: http://www.xbrl.org/2003/role/exampleRef -Topic 220 -SubTopic 40 -Name Accounting Standards Codification -Section 55 -Paragraph 14 -Publisher FASB -URI https://asc.fasb.org/1943274/2147476153/220-40-55-14 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 41 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-41 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 42 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-42 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 7 -Publisher FASB -URI https://asc.fasb.org/1943274/2147479806/606-10-50-7 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 270 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (i) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1 Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 32 -Subparagraph (ee) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32 Reference 8: http://fasb.org/us-gaap/role/ref/otherTransitionRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 32 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32 Reference 9: http://fasb.org/us-gaap/role/ref/otherTransitionRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 32 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32 Reference 10: http://www.xbrl.org/2003/role/disclosureRef -Topic 924 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SAB Topic 11.L) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479941/924-10-S99-1 Reference 11: http://www.xbrl.org/2003/role/disclosureRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 5 -Publisher FASB -URI https://asc.fasb.org/1943274/2147479806/606-10-50-5 Reference 12: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 30 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30 Reference 13: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 22 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22 Reference 14: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 40 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-40 Reference 15: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 22 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22 Reference 16: http://www.xbrl.org/2003/role/disclosureRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 4 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479806/606-10-50-4 + Details
Name: | us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Details
Name: | srt_ProductOrServiceAxis=btsg_CommercialInsuranceMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ProductOrServiceAxis=btsg_MedicaidMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ProductOrServiceAxis=btsg_MedicareAMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ProductOrServiceAxis=btsg_MedicareBMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ProductOrServiceAxis=btsg_MedicareCMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ProductOrServiceAxis=btsg_MedicareDMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ProductOrServiceAxis=btsg_PrivateAndOtherMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementBusinessSegmentsAxis=btsg_PharmacySolutionsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementBusinessSegmentsAxis=btsg_ProviderServicesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ConcentrationRiskByTypeAxis=us-gaap_ProductConcentrationRiskMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |